Pathogenesis and Management of Septic Shock

This publication has 50 references indexed in Scilit:

• A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.
  Journal of Clinical Investigation, 1985
• Stimulation of Muscle Protein Degradation and Prostaglandin E₂Release by Leukocytic Pyrogen (Interleukin-1)
  New England Journal of Medicine, 1983
• Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock
  Nature, 1978
• Prostaglandins and the hemodynamic course of endotoxin shock
  Journal of Surgical Research, 1976
• Endotoxin, prekallikrein, complement and systemic vascular resistance
  The American Journal of Medicine, 1975
• Activation of the Properdin Pathway of Complement in Patients with Gram-Negative Bacteremia
  New England Journal of Medicine, 1975
• Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia
  Annals of Internal Medicine, 1970
• Origin of myocardial depressant factor in shock
  American Journal of Physiology-Legacy Content, 1970
• INFECTIONS DUE TO GRAM-NEGATIVE ORGANISMS: AN ANALYSIS OF 860 PATIENTS WITH BACTEREMIA AT THE UNIVERSITY OF MINNESOTA MEDICAL CENTER, 1958–1966
  Medicine, 1969
• Changes in the Blood Coagulation System Associated with Septicemia
  New England Journal of Medicine, 1968